Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene-Reference-Cited by-同舟云学术

Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene

Published:2022-08 Issue:2 Volume:162 Page:385-393
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Elia Davide,Torre Olga,Vasco Chiara,Geginat Jens,Abrignani Sergio,Bulgheroni Elisabetta,Carelli Elena,Cassandro Roberto,Pacheco-Rodriguez Gustavo,Steagall Wendy K.,Moss Joel,Harari Sergio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference37 articles.

1. The changing face of a rare disease: lymphangioleiomyomatosis;Harari;Eur Respir J,2015

2. Management of lymphangioleiomyomatosis;Taveira-DaSilva;F1000Prime Rep,2014

3. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features;Ferrans;J Nippon Med Sch,2000

4. The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis;Taveira-DaSilva;Lymphat Res Biol,2010

5. Two genetic hits (more or less) to cancer;Knudson;Nat Rev Cancer,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphangioleiomyomatosis;La Presse Médicale;2023-09

2. Diffuse cystic lung diseases including lymphangioleiomyomatosis;Rare Diseases of the Respiratory System;2023-06-01

3. The world of rare interstitial lung diseases;European Respiratory Review;2023-02-07

4. New trends in cystic lung diseases;Medicom Conference Report ERS 2022;2022-10-30

5. Rapamycin nanoparticles improves drug bioavailability in PLAM treatment by interstitial injection;Orphanet Journal of Rare Diseases;2022-09-09